We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
-16.97%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$9.02B
AUM Growth
-$307M
Cap. Flow
-$225M
Cap. Flow %
-2.49%
Top 10 Hldgs %
20.75%
Holding
813
New
30
Increased
168
Reduced
3
Closed
20

Top Buys

Rank Stock Value
1
HLT icon
Hilton Worldwide
HLT
+$11.3M
2
PRNB
Principia Biopharma Inc. Common Stock
PRNB
+$2.97M
3
IVZ icon
Invesco
IVZ
+$1.15M
4
MSFT icon
Microsoft
MSFT
+$13.8K
5
AAPL icon
Apple
AAPL
+$12.4K

Top Sells

Rank Stock Value
1
MDCO
Medicines Co
MDCO
+$13.3M
2
WCG
Wellcare Health Plans, Inc.
WCG
+$12.5M
3
INST
Instructure, Inc.
INST
+$9.03M
4
DERM
Dermira, Inc.
DERM
+$8.64M
5
EQH icon
Equitable Holdings
EQH
+$7.36M

Sector Composition

Rank Sector Weight
1 Healthcare 30.92%
2 Technology 19.71%
3 Financials 10.21%
4 Consumer Discretionary 9.38%
5 Communication Services 8.35%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RDUS
326
DELISTED
Radius Health, Inc.
RDUS
$5.16M 0.06%
262,025
– –
RY icon
327
Royal Bank of Canada
RY
$293B
$5.13M 0.06%
66,272
– –
RIGL icon
328
Rigel Pharmaceuticals
RIGL
$681M
$5.11M 0.06%
244,300
– –
RDNT icon
329
RadNet
RDNT
$5.01B
$5.09M 0.06%
256,392
+22
+0% +$414
ATO icon
330
Atmos Energy
ATO
$29B
$5.08M 0.06%
46,504
+21
+0% +$2.31K
CMI icon
331
Cummins
CMI
$88.4B
$5.08M 0.06%
29,013
+4
+0% +$624
RARE icon
332
Ultragenyx Pharmaceutical
RARE
$2.46B
$5.07M 0.06%
121,500
– –
TRV icon
333
Travelers Companies
TRV
$78.8B
$5.07M 0.06%
37,895
+20
+0.1% +$2.49K
MYOK
334
DELISTED
MyoKardia, Inc. Common Stock
MYOK
$5.02M 0.06%
70,500
– –
IBN icon
335
ICICI Bank
IBN
$108B
$5M 0.06%
339,177
– –
QRVO icon
336
Qorvo
QRVO
$7.98B
$4.98M 0.06%
43,865
– –
UGI icon
337
UGI
UGI
$7.77B
$4.94M 0.05%
111,979
– –
WMS icon
338
Advanced Drainage Systems
WMS
$10.7B
$4.93M 0.05%
129,753
+48
+0% +$1.94K
MAS icon
339
Masco
MAS
$14.1B
$4.9M 0.05%
104,499
+38
+0% +$1.66K
ETFC
340
DELISTED
E*Trade Financial Corporation
ETFC
$4.89M 0.05%
110,284
+27
+0% +$1.14K
KEY icon
341
KeyCorp
KEY
$24.3B
$4.88M 0.05%
246,891
– –
AZN icon
342
AstraZeneca
AZN
$264B
$4.88M 0.05%
50,040
+32
+0.1% +$3.01K
SPG icon
343
Simon Property Group
SPG
$74.9B
$4.87M 0.05%
33,428
– –
BAX icon
344
Baxter International
BAX
$13.6B
$4.83M 0.05%
59,147
+9
+0% +$777
CSX icon
345
CSX Corp
CSX
$93.5B
$4.81M 0.05%
203,949
– –
OC icon
346
Owens Corning
OC
$11.2B
$4.76M 0.05%
74,813
– –
FISV
347
Fiserv Inc
FISV
$28.6B
$4.73M 0.05%
41,885
– –
WMT icon
348
Walmart Inc
WMT
$885B
$4.73M 0.05%
122,259
– –
IOVA icon
349
Iovance Biotherapeutics
IOVA
$1.84B
$4.7M 0.05%
173,504
+26
+0% +$689
CF icon
350
CF Industries
CF
$19.2B
$4.67M 0.05%
100,180
– –
12 13
14
15 16

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return
SPIA
Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return

Candriam SCA's Q1 2020 Portfolio in Review

As of Q1 2020, Candriam SCA held 813 positions worth $9.02B, down 3.3% from $9.33B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Candriam SCA's Q1 2020 filing shows 30 new, 168 increased, 3 reduced and 20 closed positions. Its largest new stake was Hilton Worldwide: 116,476 shares worth $21.1M. The largest sale was Medicines Co, an estimated $13.3M.

By sector, the portfolio is most concentrated in Healthcare at 31% of assets, up from 31% a quarter earlier, followed by Technology and Financials.

  • Candriam SCA's largest Q1 2020 buy was Hilton Worldwide: 116,476 shares worth $21.1M.
  • Candriam SCA added most to Microsoft in Q1 2020, an estimated $13.8K increase.
  • Candriam SCA's biggest Q1 2020 reduction was Telus, cutting an estimated $1.67M.
  • Candriam SCA fully exited Medicines Co in Q1 2020, selling an estimated $13.3M.
  • Candriam SCA's ten largest holdings make up 21% of its $9.02B portfolio in Q1 2020.
  • Candriam SCA opened 30 new positions and closed 20 in Q1 2020.
  • Candriam SCA's portfolio value fell 3.3% quarter-over-quarter to $9.02B.

Based on Candriam SCA's 13F filing for Q1 2020, filed 26 May 2020.